Sign inJoin waitlistJoin the waitlist

Eddy Yang

Chair, Department of Radiation Medicine · University of Kentucky College of Medicine

Credentials: · · · · ·

History

Department of Radiation Medicine · University of Kentucky College of Medicine
Present
Vanderbilt University Medical Center
Present
University of Kentucky College of Medicine
Present

Radiation Oncology
Vanderbilt University Medical Center
2006–2010
Preliminary or Transitional Year
2005–2006
Univ of Miami Leonard M. Miller Sch of Med
2001–2005

Research

Early Time-Restricted Feeding Improves 24-Hour Glucose Levels and Affects Markers of the Circadian Clock, Aging, and Autophagy in Humans
Nutrients · 2019 · 520 citations
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
Journal of Clinical Oncology · 2020 · 407 citations
Genomic instability in human cancer: Molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition
Review · Seminars in Cancer Biology · 2015 · 228 citations

James Bonner
19 papers
SN
Somaira Nowsheen
19 papers
Christopher Willey
18 papers · 1 as a fellow
Andrew McDonald
15 papers · 7 as a resident
John Fiveash
14 papers
TC
Tiffiny Cooper
13 papers
Soroush Rais-Bahrami
11 papers
Chris Dobelbower
10 papers
Rojymon Jacob
10 papers
Fen Xia
9 papers
GS
Guru Sonpavde
8 papers
Jeffrey Nix
8 papers

Grants

Combine Mitochondrial Gene Therapy and Synthetic Lethal Chemotherapy to Treat Triple-Negative Breast Cancer
National Cancer Institute · R01
PI · $2.8M · Ohio State University
2022–2027
Comprehensive Cancer Center Support Grant
National Cancer Institute · P30
Project lead · $381.1K · University of Alabama at Birmingham
1997–2027
NCTN Deep South Research Consortium
National Cancer Institute · UG1
PI · $1M · University of Alabama at Birmingham
2019–2025
General Clinical Research Center
National Center for Research Resources · M01
Project lead · $6.5K · Vanderbilt University
2006–2007

Clinical trials

Abemaciclib and Pembrolizumab in Metastatic or Recurrent Head and Neck Cancer
Principal investigator · Terminated · Phase 2
University of Alabama at Birmingham
2019–2020
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Site PI · Recruiting · Phase 1
Orano Med Theranostics, SAS
2022–2032